These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28276813)

  • 1. Fecal biomarkers in inflammatory bowel disease: how, when and why?
    Ministro P; Martins D
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):317-328. PubMed ID: 28276813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease monitoring in inflammatory bowel disease.
    Chang S; Malter L; Hudesman D
    World J Gastroenterol; 2015 Oct; 21(40):11246-59. PubMed ID: 26523100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
    J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to predict clinical relapse in inflammatory bowel disease patients.
    Liverani E; Scaioli E; Digby RJ; Bellanova M; Belluzzi A
    World J Gastroenterol; 2016 Jan; 22(3):1017-33. PubMed ID: 26811644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of treatment outcome and relapse in inflammatory bowel disease.
    Kato J; Yoshida T; Hiraoka S
    Expert Rev Clin Immunol; 2019 Jun; 15(6):667-677. PubMed ID: 30873890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.
    Kopylov U; Rosenfeld G; Bressler B; Seidman E
    Inflamm Bowel Dis; 2014 Apr; 20(4):742-56. PubMed ID: 24562174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal lactoferrin, a marker of intestinal inflammation in children with inflammatory bowel disease.
    Borkowska A; Liberek A; Łuczak G; Jankowska A; Plata-Nazar K; Korzon M; Kamińska B
    Acta Biochim Pol; 2015; 62(3):541-5. PubMed ID: 26339799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review.
    Bannaga AS; Farrugia A; Arasaradnam RP
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1113-1122. PubMed ID: 31657950
    [No Abstract]   [Full Text] [Related]  

  • 10. Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.
    Ferreiro-Iglesias R; Barreiro-de Acosta M; Otero Santiago M; Lorenzo Gonzalez A; Alonso de la Peña C; Benitez Estevez AJ; Dominguez-Muñoz JE
    J Clin Gastroenterol; 2016 Feb; 50(2):147-51. PubMed ID: 25811118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.
    Rosenfeld G; Greenup AJ; Round A; Takach O; Halparin L; Saadeddin A; Ho JK; Lee T; Enns R; Bressler B
    World J Gastroenterol; 2016 Sep; 22(36):8211-8. PubMed ID: 27688663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
    Kanmura S; Hamamoto H; Morinaga Y; Oda K; Fujita T; Arima S; Nasu Y; Sasaki F; Hashimoto S; Taguchi H; Setoyama H; Ido A
    Digestion; 2016; 93(4):300-8. PubMed ID: 27220673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody markers in the diagnosis of inflammatory bowel disease.
    Mitsuyama K; Niwa M; Takedatsu H; Yamasaki H; Kuwaki K; Yoshioka S; Yamauchi R; Fukunaga S; Torimura T
    World J Gastroenterol; 2016 Jan; 22(3):1304-10. PubMed ID: 26811667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG; Gomollon F
    Inflamm Bowel Dis; 2009 Nov; 15(11):1746-54. PubMed ID: 19363798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
    Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL
    Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fecal biomarkers in individuals with inflammatory bowel disease.
    Edwards TS; Day AS
    Expert Rev Mol Diagn; 2024 Jun; 24(6):497-508. PubMed ID: 38995110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
    Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH;
    Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The status of diagnostic markers for inflammatory bowel disease.
    Beniwal P; Harrell L
    Curr Gastroenterol Rep; 2010 Dec; 12(6):479-84. PubMed ID: 20890737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.